However, it should be stressed that the available data on the ratio of involved organs in the patients with IIS are different from natural sarcoidosis [4], so it is most probable that IFN-β, similar to IFN-α, can cause sarcoidosis in patients with MS due to its immunomodulatory properties. This evidence concerns the gene IFNB1 and myeloid sarcoma.